---
schema_version: "secwatch.filing_event.v1"
accession: "0001746473-24-000084"
form_type: "8-K"
ticker: "PLRX"
cik: "0001746473"
company_name: "PLIANT THERAPEUTICS, INC."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:22:14.985402+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Pliant Therapeutics say-on-pay vote fails; Krognes appointed to board

## Summary
- Non-binding say-on-pay vote failed: 23,479,353 for, 28,329,655 against, 10,277 abstain.
- Steve Krognes appointed as Class III director and Audit Committee chair; receives option for 53,528 shares vesting over 3 years.
- Board size increased from 10 to 11 members to accommodate Krognes.
- Deloitte & Touche LLP ratified as auditor for FY2024: 56,628,368 for, 10,853 against, 62,998 abstain.

## SEC filing metadata
- accession: 0001746473-24-000084
- form_type: 8-K
- ticker: PLRX
- cik: 0001746473
- company_name: PLIANT THERAPEUTICS, INC.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746473/000174647324000084/0001746473-24-000084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746473/000174647324000084/plrx-20240613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001746473-24-000084
- JSON: https://secwatch.observer/filing/0001746473-24-000084.json
- Plain text: https://secwatch.observer/filing/0001746473-24-000084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.